Orchestra Biomed Holdings, Inc. (OBIO) SEC Filings — 2025
15 SEC filings for Orchestra Biomed Holdings, Inc. (OBIO) in 2025.
Filings
- Orchestra Biomed Holdings, Inc. 8-K Filing — 8-K · Nov 13, 2025
- Orchestra BioMed's Q3 Loss Widens Amid R&D Surge, Revenue Dip — 10-Q · Nov 10, 2025
- Orchestra BioMed Holdings Files 8-K — 8-K · Oct 30, 2025
- Orchestra BioMed Files 8-K on Agreements and Equity Sales — 8-K · Oct 28, 2025
- Orchestra BioMed's Net Loss Widens 29% Amid Soaring R&D Costs — 10-Q · Aug 12, 2025
- Orchestra BioMed Holdings, Inc. Enters Material Definitive Agreement — 8-K · Aug 4, 2025
- Orchestra BioMed Files 8-K with Material Agreements — 8-K · Jul 31, 2025
- Orchestra BioMed Holdings Files 8-K on Shareholder Vote — 8-K · Jun 24, 2025
- Orchestra BioMed Holdings Files 10-Q for Q1 2025 — 10-Q · May 12, 2025
- Orchestra BioMed Holdings Files Definitive Proxy Statement — DEF 14A · Apr 30, 2025
- Orchestra BioMed Holdings Files 8-K — 8-K · Apr 29, 2025
- Orchestra BioMed Files 2024 Annual Report — 10-K · Mar 31, 2025
- Orchestra BioMed Holdings Files 8-K — 8-K · Mar 3, 2025
- Orchestra BioMed Appoints New Chief Medical Officer — 8-K · Feb 25, 2025
- Orchestra BioMed Holdings Announces Board and Compensation Changes — 8-K · Feb 5, 2025